MDMA-assisted therapy for moderate to severe PTSD: a randomized, placebo-controlled phase 3 trial.

RTHM-017552023Mitchell, Jennifer M; Ot'alora G, Marcela; van der Kolk, Bessel; Shannon, Scott; Bogenschutz, Michael; Gelfand, Yevgeniy; Paleos, Casey; Nicholas, Christopher R; Quevedo, Sylvestre; Balliett, Brooke; Hamilton, Scott; Mithoefer, Michael; Kleiman, Sarah; Parker-Guilbert, Kelly; Tzarfaty, Keren; Harrison, Charlotte; de Boer, Alberdina; Doblin, Rick; Yazar-Klosinski, Berra

This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.

Read the original research

MDMA-assisted therapy for moderate to severe PTSD: a randomized, placebo-controlled phase 3 trial.

Nature medicine, 29(10), 2473-2480

View on PubMed ↗Publisher’s paper ↗

Citation

Mitchell, Jennifer M; Ot'alora G, Marcela; van der Kolk, Bessel; Shannon, Scott; Bogenschutz, Michael; Gelfand, Yevgeniy; Paleos, Casey; Nicholas, Christopher R; Quevedo, Sylvestre; Balliett, Brooke; Hamilton, Scott; Mithoefer, Michael; Kleiman, Sarah; Parker-Guilbert, Kelly; Tzarfaty, Keren; Harrison, Charlotte; de Boer, Alberdina; Doblin, Rick; Yazar-Klosinski, Berra. (2023). MDMA-assisted therapy for moderate to severe PTSD: a randomized, placebo-controlled phase 3 trial.. Nature medicine, 29(10), 2473-2480. https://doi.org/10.1038/s41591-023-02565-4